US Patent Issued to Inhibrx Biosciences on May 13 for "PD-1 single domain antibodies and therapeutic compositions thereof" (California Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,271, issued on May 13, was assigned to Inhibrx Biosciences Inc. (La Jolla, Calif.).

"PD-1 single domain antibodies and therapeutic compositions thereof" was invented by Rajay A. Pandit (La Jolla, Calif.), John C. Timmer (San Diego), Angelica N. Sanabria (La Jolla, Calif.), Florian Sulzmaier (San Diego) and Brendan P. Eckelman (Encinitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are binding polypeptides that specifically bind PD-1. More specifically, provided herein are fusion proteins, including multivalent and/or multispecific constructs and chimeric antigen receptors, that bind PD-1. Also provided are pharmaceutical co...